BioCentury
ARTICLE | Company News

Cevec Pharmaceuticals, Provecs Medical, Medac deal

March 24, 2017 7:12 PM UTC

Cevec granted Provecs and Medac non-exclusive licenses to use Cevec's CAP-GT technology which the companies will use to jointly develop and commercialize Provecs' Immunalon to treat urinary bladder ca...